HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

New approach to noninvasive coronary angiography by multidetector computed tomography: initial experience using gadolinium.

AbstractOBJECTIVE:
To investigate the gadolinium performance for 16-detector-row coronary computed tomography (CT) angiography.
METHODS:
Ethics committee approval and informed consent were obtained. Ten patients with coronary artery disease underwent digital coronary angiography and gadolinium-enhanced CT coronary angiography (Gd-CTCA) within the same week. For the Gd-CTCA, each patient received a dose of 0.3 mmol/kg of body weight of 0.5 mmol/mL gadoterate meglumine. Two readers interpreted the CT angiographies independently, and their results were matched with the digital angiography findings. The diagnostic accuracy of Gd-CTCA was calculated by the exact binomial method.
RESULTS:
Sensitivity, specificity, and positive and negative predictive values were for observer 1: 91.67%, 98.73%, 84.62%, and 99.36%, and for observer 2: 83.33%, 98.73%, 83.33%, and 98.73%, respectively.
CONCLUSION:
Preliminary results demonstrated that gadolinium chelates may be used as an alternative CT contrast media in coronary CT angiographies, without detriment to diagnosis results.
AuthorsPatricia Carrascosa, Pablo Garcia Merletti, Carlos Capuñay, Alejandro Goldsmit, Marcelo Bettinotti, Jorge Carrascosa
JournalJournal of computer assisted tomography (J Comput Assist Tomogr) 2007 May-Jun Vol. 31 Issue 3 Pg. 441-3 ISSN: 0363-8715 [Print] United States
PMID17538293 (Publication Type: Journal Article)
Chemical References
  • Contrast Media
  • Organometallic Compounds
  • Meglumine
  • gadoterate meglumine
Topics
  • Cardiovascular Diseases (diagnostic imaging)
  • Contrast Media
  • Coronary Angiography (methods)
  • Humans
  • Male
  • Meglumine
  • Middle Aged
  • Organometallic Compounds
  • Predictive Value of Tests
  • Sensitivity and Specificity
  • Tomography, X-Ray Computed

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: